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Strengths and limitations of this study
 ► The broad inclusion criteria allowed the inclusion of 
a wide variety of patients with suspected sepsis.
 ► Patients with missing data were not excluded.
 ► Patients whose final diagnosis was not related to an 
infection/sepsis were included.
 ► Patients discharged from the emergency depart-
ment were not studied.
 ► A single-centre study that requires external 
validation.
ABSTRACT
Objective To derive and validate a new clinical prediction 
rule to risk-stratify emergency department (ED) patients 
admitted with suspected sepsis.
Design Retrospective prognostic study of prospectively 
collected data.
Setting ED.
Participants Patients aged ≥18 years who met two 
Systemic Inflammatory Response Syndrome criteria 
or one Red Flag sepsis criteria on arrival, received 
intravenous antibiotics for a suspected infection and 
admitted.
Primary outcome measure In-hospital all-cause 
mortality.
Method The data were divided into derivation and 
validation cohorts. The simplified-Mortality in Severe 
Sepsis in the ED score and quick-SOFA scores, refractory 
hypotension and lactate were collectively termed 
‘component scores’ and cumulatively termed the ‘Risk-
stratification of ED suspected Sepsis (REDS) score’. Each 
patient in the derivation cohort received a score (0–3) for 
each component score. The REDS score ranged from 0 
to 12. The component scores were subject to univariate 
and multivariate logistic regression analyses. The receiver 
operator characteristic (ROC) curves for the REDS and the 
components scores were constructed and their cut-off 
points identified. Scores above the cut-off points were 
deemed high-risk. The area under the ROC (AUROC) curves 
and sensitivity for mortality of the high-risk category of the 
REDS score and component scores were compared. The 
REDS score was internally validated.
Results 2115 patients of whom 282 (13.3%) died in 
hospital. Derivation cohort: 1078 patients with 140 deaths 
(13%). The AUROC curve with 95% CI, cut-off point and 
sensitivity for mortality (95% CI) of the high-risk category 
of the REDS score were: derivation: 0.78 (0.75 to 0.80); 
≥3; 85.0 (78 to 90.5). Validation: 0.74 (0.71 to 0.76); ≥3; 
84.5 (77.5 to 90.0). The AUROC curve and the sensitivity 
for mortality of the REDS score was better than that of the 
component scores. Specificity and mortality rates for REDS 
scores of ≥3, ≥5 and ≥7 were 54.8%, 88.8% and 96.9% 
and 21.8%, 36.0% and 49.1%, respectively.
Conclusion The REDS score is a simple and objective 
score to risk-stratify ED patients with suspected sepsis.
InTRODuCTIOn
Sepsis, a life-threatening condition,1 is best 
managed by early recognition and treat-
ment.2 The majority of patients in hospital 
with sepsis are admitted as an emergency 
with community acquired sepsis.3 It is there-
fore important to identify patients at highest 
risk of death in the emergency department 
(ED). Identification of the high-risk patients 
will both facilitate increased focus of care and 
also helps determine the transfer destination. 
In addition, it facilitates the initiation of a 
conversation on prognosis.
Patients at high-risk of death may be identi-
fied by using an evidence based risk-stratifica-
tion score. The ED is a pressured environment 
and any score that is used should be easy to 
calculate using readily available variables. The 
objective criteria defining sepsis, a minimum 
two-point increase,1 in the Sequential Organ 
Failure Assessment (SOFA) score,4 corre-
sponds to a mortality rate of over 10%. Calcu-
lation of the change in SOFA score in a busy 
ED is at best labour intensive, as it requires 
the calculation of the presenting and base-
line SOFA scores, and at worst inaccurate as 
some of the criteria are not met or routinely 
measured in the ED.
The quick-SOFA (qSOFA) score5 was 
created to risk-stratify patients without the 
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need for blood tests and has three variables: respiratory 
rate (RR) ≥22/min, systolic blood pressure (SBP) ≤100 
mm Hg and altered mental state. The presence of ≥2 
variables places the patient in a high-risk category for 
mortality. Prospective validation studies of the qSOFA 
score in the ED have found the sensitivity for mortality to 
vary between 30% and 70%,6–9 a rule-in score that cannot 
be used alone. The Mortality in Severe Sepsis in the ED 
score (MISSED score)10 11 is another scoring system that 
has been derived, validated and simplified. The simpli-
fied-MISSED (sMISSED) score12 has been externally 
validated,13 and like the qSOFA score has only three vari-
ables: age ≥65 years, serum albumin ≤27 g/L and an inter-
national normalised ratio (INR) ≥1.3, scoring one point 
each when present; scores of ≥2 places the patient in a 
high-risk category for mortality.
The most widely studied high-risk criteria in sepsis are 
refractory hypotension (RH); (RH=low blood pressure 
(BP) after an adequate fluid bolus needing vasopressors 
to maintain a mean arterial pressure (MAP) >65 mm 
Hg),1 and high lactate (HL); HL=lactate ≥4 mmol/L.14 15 
But not all patients who go on to die meet these criteria 
while in the ED. We have previously reported that 71% 
of patients who die in hospital can be identified by using 
a combination of a sMISSED score of ≥2, RH and HL.12
The aim of this study is to derive and validate a new 
scoring system combining the sMISSED and qSOFA scores 
with RH and lactate, to Risk-stratify ED suspected Sepsis 
(REDS) patients for in-hospital mortality. The cut-off 
point of the receiver operator characteristic (ROC) curve 
will stratify patients into high-risk and low-risk categories. 
The performance of the REDS score will be compared 
with that of the sMISSED and qSOFA scores, RH and 
lactate based on the following criteria:
1. the area under the ROC (AUROC) curve and
2. the sensitivity for mortality in the high-risk category.
MeThODS
Study design, time period and setting
A prospectively collected convenience sample of adults 
aged ≥18 years who received intravenous antibiotics in the 
ED for suspected sepsis and admitted between 8 February 
2016 and 31 August 2017 were studied. The study popu-
lation was divided chronologically in half into derivation 
and validation cohorts, by dividing the population along 
the number of deaths. This study was carried out in the 
ED of an urban University Teaching major trauma centre 
with 120 000 annual adult attendances.
Participant selection and measurements
Inclusion criteria: all patients presenting to the ED who 
met the criteria in either of the following two categories:
1. Patients who met any one of the following Red Flag16 
criteria on arrival:
 ► Unwell within 6 weeks of chemotherapy.
 ► RR >25/min.
 ► Heart rate (HR) >130/min.
 ► SBP <90 mm Hg or MAP <65 mm Hg.
 ► Reduced alertness.
 ► New requirement for oxygen to maintain saturations 
>90%.
 ► Temperature ≤35°C.
 ► A non-blanching rash.
2. Patients who met any two of the following expanded 
Systemic Inflammatory Response Syndrome (SIRS)17 
criteria on arrival:
 ► RR >20/min.
 ► HR >90/min.
 ► Temperature <36°C or>38°C.
 ► White cell count <4 or >12×109/l (if available on 
arrival).
 ► New confusion.
 ► Blood glucose >7.7 mmol/L in non-diabetics.
Data were collected retrospectively from the ED notes 
and the electronic patient records and entered into 
an electronic spreadsheet. All data were checked by a 
second researcher for accuracy. The data collected were 
as follows: date of admission, method of arrival, initial 
vital signs (RR, HR, BP, oxygen saturations, tempera-
ture, blood glucose, altered mental status), final BP, 
initial lactate, serum albumin, INR, the use of warfarin 
or directly acting oral anticoagulants, white cell count, 
in those patients who received a minimum 2 L of fluids 
the BP and lactate after the second litre of fluid, the 
ability to live independently, final diagnosis, ICU admis-
sion, date of discharge and outcome at discharge. The 
highest RR, lowest SBP and highest lactate in the ED was 
also collected for the derivation cohort. The number of 
SIRS criteria,17 met, do not attempt resuscitation (DNAR) 
orders made in the community and the ED were noted. 
Hospital length of stay (HLOS) was calculated from the 
date of admission and discharge. The following were 
coded as RH: MAP of <62 mm Hg after a minimum 2 L 
fluid bolus or 30 mL/kg, a MAP ≤55 mm Hg after less 
than 2 L of fluid or commencement of vasopressors in the 
ED. Patients who had vasopressors commenced only to 
compensate hypotension induced by anaesthetic agents 
were not coded as RH.
Outcome measures
Primary endpoint: n-hospital all-cause mortality. Patients 
discharged on a palliative care pathway and died within 
15 days of discharge were counted as in-hospital deaths.
Data analysis
The baseline characteristics of the derivation and valida-
tion populations were compared to understand if there 
were any difference in the populations.
Derivation and construction of the ReDS score
The OR for mortality for HL (initial lactate) and RH were 
calculated and compared with the OR for mortality of the 
high-risk qSOFA (initial vital signs) and sMISSED scores. 
RH and lactate were transformed into scoring systems by 
the allocation of scores 0–3. Each patient had a qSOFA, 
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sMISSED, RH and a lactate score (collectively referred to 
as component scores) calculated. The component scores 
were subject to univariate analysis (UVA) followed by 
multivariate logistic regression (MVLR) and construction 
of a MVLR model. The cumulative value of the compo-
nent scores formed the REDS score. ROC curves were 
constructed for the REDS score and the component 
scores for the primary point. The AUROC curves were 
calculated and compared. The optimal cut-off point as 
determined by the statistical software programme was 
used to stratify patients into high-risk and low-risk cate-
gories. The test-characteristics of the high-risk category 
of the REDS score and the component scores were calcu-
lated. The REDS score was validated in the latter half of 
the data set. Mortality rates associated with each score 0–3 
for the component scores and 0–12 for the REDS score 
were calculated.
MedCalc Statistical Software V.18.1 was used for statis-
tical analysis. UVA on continuous data was tested using 
the Student’s t-test when normally distributed and the 
Mann-Whitney test when normality was rejected. The χ2 
test was used for categorical data. Statistical significance 
was defined as p<0.05.
An MVLR model was constructed using the ‘Enter’ 
method. Variables were entered if p<0.05 and removed 
if p>0.1. The OR for mortality in the MVLR model was 
assessed for the need to weight the scores. Discrimination 
and calibration of the model were assessed by the AUROC 
curve and the Hosmer-Lemeshow test,18 respectively. The 
difference in AUROC curves was assessed by the DeLong 
method.19
Variants of the ReDS score in the derivation cohort
Alternative qSOFA scores in the REDS score
The REDS score was recalculated using the final RR and 
SBP and the highest RR and lowest SBP in the qSOFA 
score, mental state was assumed to be unchanged as any 
subtle changes may not have been accurately documented.
The highest lactate in the REDS score
The REDS score was recalculated using the highest lactate 
instead of the initial lactate.
RH as a homogeneous population in the REDS score
The REDS score was recalculated assuming that RH was a 
homogeneous population, thereby not stratifying RH by 
the associated lactate.
Exclusion of patients with missing variables
The REDS score was also studied after excluding the 
population of patients with missing variables but main-
taining those who were on oral anticoagulants, although 
scoring 0 for INR.
The AUROC curves, the cut-off points and the test-char-
acteristics of the high-risk group were also studied for 
these variants of the REDS score.
Validation study
The REDS score was validated in the latter part of the 
data set. This was done by calculating the REDS score for 
each patient, constructing ROC curves, identifying the 
cut-off point, stratifying patients by the cut-off point and 
studying the test-characteristics of the high-risk group.
Sample size and missing variables
Steill and Wells 20 advocate a minimum 10 outcomes per 
variable. An adequate sample size for the derivation and 
validation populations would have a minimum 80 deaths 
each when values for all eight variables (age, BP, mental 
status, RR, INR, serum albumin, lactate and RH) were 
present. Missing variables were assumed to be normal. 
Those on oral anticoagulants were given a score of 0 for 
INR. This pragmatic approach would reflect future clin-
ical use.
Patient and public involvement
No patients or the public were involved in the develop-
ment of the research question or conduct of the study.
Data availability
All data used are included in the manuscript.
ReSulTS
Baseline characteristics of the derivation and validation 
populations are found in table 1. The baseline character-
istics of the derivation and validation populations were 
similar. The difference in the percentage of patients 
admitted to the ICU is likely to reflect seasonality. Of the 
120 patients with RH, only seven received less than 2 L of 
fluid.
Derivation study
Of the 1093 patients collected between 8 February and 4 
October 2016, ED notes were unavailable for 15. Of the 
remaining 1078 patients 140 died. Missing results: lactate 
54, serum albumin 49, INR 107 and another 107 were 
on oral anticoagulants. Ninety of the 791 patients with 
results for all variables and not on oral anticoagulants, 
died. Normality was rejected for all continuous variables.
The OR for mortality for HL and RH were similar to 
that for the high-risk categories of the sMISSED and 
qSOFA scores (table 2A).
Lactate and RH were transformed into scoring systems 
by allocating scores which had mortality rates similar to 
the corresponding scores in the sMISSED and qSOFA 
scores, as described in figure 1. Lactates ≥4 mmol/L were 
scored 3. ‘Low-risk’ lactates (0–3.9 mmol/L) were further 
stratified,21 : lactates 2.1–3.9 mmol/L were scored 1 and 
≤2 mmol/L scored 0. The overall mortality rate of 39.7% 
for RH would indicate a score of 3 for all RH. RH is known 
to have a higher mortality rate when associated with a 
lactate >2 mmol/L.22 Therefore, RH was scored 3 when 
the associated lactate was >2 mmol/L after 2 L of crystal-
loid and scored 2 if the lactate was ≤2 mmol/L. When the 
lactate postfluid bolus was not available, the initial lactate 
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Figure 1 The Risk-stratification of Emergency Department suspected Sepsis (REDS) score. DOAC, directly acting oral 
anticoagulants; INR, international normalised ratio; MAP, mean arterial pressure; RH, refractory hypotension.
Figure 2 Mortality rates associated with each score of (A) the component scores, (B) the REDS score and (C) the receiver 
operator characteristics of the REDS and component scores.
was used to stratify RH. Mortality rates for each score 0–3 
for each component score are shown in figure 2A.
UVA followed by MVLR confirmed all component scores 
to be independent predictors of mortality (table 2B). The 
AUROC curve for the MVLR model was 0.79 (95%CI 0.76 
to 0.81); Hosmer-Lemeshow test confirmed good calibra-
tion, p=0.58. The AUROC curve of the REDS score 0.78 
(95%CI 0.75 to 0.80) was similar to that of the regression Protected by copyright.
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Table 2A OR of high-risk and low-risk criteria of the component criteria
Score
Low-risk scores 0–1 High-risk scores 2–3
OR for mortality (95% CI) SignificanceNumber Deaths Number Deaths
qSOFA 778 65 300 75 3.66 (2.54 to 5.26) p<0.0001
sMISSED 822 66 256 74 4.66 (3.22 to 6.74) p<0.0001
  Absence of HL/RH Presence of HL/RH OR for mortality (95% CI) Significance
Number Deaths Number Deaths
High lactate 975 107 103 33 3.82 (2.41 to 6.06) p<0.0001
Refractory hypotension 1015 115 63 25 5.15 (3.00 to 8.84) p<0.0001
HL, high lactate ≥4 mmol/L; RH, refractory hypotension; qSOFA, quick Sequential Organ Failure Assessment score; sMISSED, simplified 
Mortality in Severe Sepsis in the Emergency Department score.
Table 2B Univariate and multivariate logistic regression analysis of the component scores
Score
Alive
Median 
(IQR)
Dead 
Median 
(IQR)
Significance 
(univariate 
analysis)
Coefficient 
of logistic 
regression
OR (95% CI) 
for mortality on 
logistic regression Significance
qSOFA 1 (1–1) 2 (1–2) <0.0001 0.7178 2.05 (1.57–2.68) p<0.0001
sMISSED 1 (0–1) 2 (1–2) <0.0001 0.9358 2.55 (1.98–3.28) p<0.0001
Lactate 0 (0–1) 1 (0–1) <0.0001 0.2277 1.26 (1.04–1.52) p=0.02
Refractory 
hypotension
0 (0–0) 0 (0–0) <0.0001 0.2546 1.29 (1.03–1.62) p=0.03
qSOFA, quick Sequential Organ Failure Assessment score; sMISSED, simplified Mortality in Severe Sepsis in the Emergency Department 
score.
model, negating the need to weight the component 
scores.
The ReDS score
Range: 0–12. Mortality rates associated with each score 
0–12 for the REDS score are presented in figure 2B. 
The cut-off point was ≥3. The REDS score had a greater 
AUROC and sensitivity for mortality in the high-risk 
category than its component scores (table 3). The ROC 
curves for the REDS score and the component scores are 
presented in figure 2C.
Variants of the ReDS score in the derivation cohort
Alternative qSOFA scores in the REDS score
There was no difference in AUROC curve or the cut-off 
points between REDS scores when the initial or final 
vital signs were used in the qSOFA score. However, when 
the highest RR and lowest SBP were used in the qSOFA 
score, the sensitivity for mortality for a qSOFA score of ≥2 
improved from 53% to 70%. Incorporating this alternate 
qSOFA score, which included the most deranged values 
for RR and SBP over a period of time rather than the 
respective values at a given point in time, in the REDS 
score moved the cut-off point of the REDS score from 3 to 
4. This change in cut-off point in the REDS score signifi-
cantly reduced the sensitivity for mortality in the high-
risk category from 85% to 61.4%. We therefore advocate 
calculating a qSOFA score using the variables measured 
at presentation (initial vital signs) or at a given point in 
time but not taking the worst variables over a period of 
time.
The highest lactate in the REDS score
Use of the highest lactate instead of the initial lactate did 
not significantly change the sensitivity for mortality of 
the high-risk category or the AUROC compared with the 
initial lactate. We therefore advocate the use of either the 
initial or highest lactate when calculating the REDS score.
RH as a homogeneous population in the REDS score
The overall mortality rate for RH was 39.7%. This would 
warrant a score of 3 for all RH. Scoring 3 for all RH did 
not change the AUROC, the cut-off point or sensitivity 
for mortality of the REDS score. However, on MVLR it 
marginally reduces the significance of RH from 0.03 to 
0.04. We therefore advocate stratifying RH by the associ-
ated lactate as it is a more accurate reflection of the risk 
of death.
Exclusion of patients with missing variables
Exclusion of patients with missing variables improved 
the AUROC curve to 0.8 and improved the sensitivity for 
mortality in the high-risk group to 90%, see table 3. The 
mortality rate for a score of 0–2 was 2.6%.
Validation study
Of the 1060 patients between 5 October 2016 and 31 
August 2017, ED notes were unavailable for 23 patients. 
Of the remaining 1037 patients, 142 died. Missing vari-
ables were lactate 42, albumin 42, INR or on oral antico-
agulants 217. Of the 763 patients who had results for all 
variables, 96 died.
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The AUROC curve of the regression model of the 
validation data was 0.74 (95%CI 0.71 to 0.77) and the 
Hosmer-Lemeshow test showed good calibration, p=0.55. 
See table 3 for the test-characteristics.
Other findings
Of the 2115 patients studied, 33 of the 44 patients who 
died with a REDS score of 0–2 and 167 of the 202 who died 
without an admission to the ICU, had one or more of the 
following five comorbidities before admission: dementia, 
required significant help with daily living (nursing home 
(NH) residency or ≥3 carer visits per day), community 
DNAR order, malignancy or were on long-term oxygen 
therapy. Three of the 73 patients with a score of 2 in one 
component score and a REDS score of 2, died. All three 
had community DNAR orders. Of the 164 patients with a 
score of 0, there were two deaths and seven ICU admis-
sions. The earliest death occurred on day 22.
Of the 259 patients admitted to the ICU during their 
hospital stay, 61 had scores of 0–2 while in the ED. The 
negative likelihood ratio for a REDS score of >0 for a 
combined endpoint of admission to the ICU or death was 
0.18 (95% CI 0.09 to 0.37).
Median HLOS for patients with a REDS scores of 3–12 
was 8 days (IQR 4–16) compared with 5 days (IQR 3–9) 
for those with scores 0–2, p<0.0001.
DISCuSSIOn
In this study, we have derived and validated the REDS 
score which combines four component scores: the qSOFA 
score, the simplified MISSED score, lactate and RH. Each 
of the component scores ranged from 0 to 3. The REDS 
score ranged from 0 to 12. A REDS score of ≥3 identi-
fied 85% (90% if all variables were measured) of patients 
who go on to die in hospital and was associated with a 
mortality rate (positive predictive value) of over 21%. A 
REDS score of 0–2 was associated with a mortality rate of 
2.6% when all variables were measured. The specificity 
and positive predictive values for mortality in patients 
with REDS scores of ≥3, ≥5 and≥7 were 54.8%, 88.8% and 
96.9%, respectively. In addition, the REDS score had a 
better AUROC curve and sensitivity for mortality in the 
high-risk category than its component scores. The REDS 
score is easy to calculate in a busy ED as it uses widely 
available variables which are primarily dichotomous and 
it embraces the current definition of septic shock.22
It can be seen from table 1 that the baseline character-
istics of the derivation and validation populations were 
similar except for a statistically significant difference in 
age and initial SBP. These two variables are key compo-
nents of two of the component scores. Despite these 
differences, a REDS score of ≥3 identified 85% of patients 
who died in each population.
While the population studied is large, there are several 
limitations to our study. It is a single-centre study and 
requires external validation. Patients not meeting the 
screening criteria and those who were discharged from 
the ED were not studied. Limiting the outcome to in-hos-
pital mortality may have resulted in the underestimation 
of mortality as patients discharged before 28 days but 
died within 28 days would not have been recognised. 
ED treatments which may have influenced outcome and 
reason for ICU admission were not studied. Some ICU 
admissions may have occurred for logistical reasons when 
staffing skill-mix and bed availability in other areas of 
the hospital were limited. This may have contributed to 
the lower sensitivity for ICU admissions in the high-risk 
group. Furthermore, we did not exclude patients whose 
final diagnosis was not related to an infection. We took 
this pragmatic view as it would reflect reality. Over 23% 
of ICU admissions had REDS scores of 0–2 while in the 
ED suggesting the REDS score may not pick-up patients 
who develop organ dysfunction. We also cannot advocate 
discharge from the ED based on a REDS score of 0, as 
the negative likelihood ratio for a REDS score >0 is 0.18 
for the composite endpoint of death or ICU admission. 
This statistic is not strong enough to support such action. 
Finally, we did not perform a sample size calculation to 
compare the AUROC curves. However, it is clear that 
the sensitivity for mortality of the REDS score above the 
cut-off point is greater than the sensitivities of the compo-
nent scores above their respective cut-off points.
The AUROC curve of the sMISSED score for mortality 
was 0.73, similar to previous reports.12 13 The AUROC 
for the qSOFA score was 0.7, similar to the AUROC of 
0.71 found by Seymour et al,5 for the community infec-
tions cohort. The sensitivity for mortality in our study 
for a qSOFA score of ≥2 was 53.6% which increased to 
70% when the highest RR and lowest SBP were used in 
the qSOFA score. This is similar to the 70% sensitivity 
for mortality found by other studies,6 7 where the worst 
reading for each variable was used. But this increased 
sensitivity for mortality was lost due to the increase in 
cut-off point of the REDS score from 3 to 4. It is our view 
that measures for RR, SBP and mental state should be 
taken at a given point in time, rather than over a period 
of time and would reflect clinical use of the score. In 
our study, a lactate of ≥4 mmol was associated with a 
32% mortality rate which is similar to the 38% mortality 
rate found by Trzeciak et al,21 who studied a population 
with a 19% mortality rate; a mortality rate higher than 
our study population. The mortality rates associated with 
the stratified RH of 25% and 46.5% for scores 2 and 3, 
respectively, were similar to the mortality rates reported 
by Shankar-Hari et al.22
From a practical point, the calculation of the REDS 
score can only be completed after the initial treatment 
bundle (antibiotics and fluid) is complete and the results 
of the serum albumin and INR are available. Therefore, 
as the name suggests the REDS score is very much a risk 
stratification tool which aids disposition from the ED. 
The clinical use of the REDS score would be based on 
the specificities and mortality rates (positive predictive 
value) of the different scores: for those with a REDS score 
of ≥7 (96.9% specificity for mortality) ICU admission is 
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mandatory. For those patients with REDS scores of ≥7 in 
whom the admission to ICU is inappropriate, a DNAR 
order should be completed prior to leaving the ED. For 
those with a score of 5–6 (88.8% specificity for mortality), 
ICU referral and transfer should be strongly considered. 
All patients with REDS scores of ≥3 should have a treat-
ment escalation plan to follow, should they deteriorate. 
Those with scores of 0–2 should follow the usual care 
pathway. Patients with RH should receive the recom-
mended care.2
With regard to future developments, the REDS score 
requires external validation, in the first instance. Further 
study is required regarding the use of the REDS in patients 
who are already admitted and the use of the REDS score 
as a monitoring tool.
COnCluSIOn
The REDS score is a new, simple and objective scoring 
system that uses widely available variables to risk-stratify 
ED patients suspected of having sepsis and is better than 
its component scores.
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